Find stats on top websites
Industry Landscape
The Parkinson's disease support and research industry is experiencing growth due to the increasing prevalence of the disease with aging populations. Advances in research are leading to new therapies and diagnostic tools, while non-profit organizations and patient advocacy groups play a crucial role in providing support, education, and resources. Competition is increasing among organizations for funding and visibility, while telehealth and virtual support options are expanding access to care.
Total Assets Under Management (AUM)
Prevalence of Parkinson's in United States
~1 million people living with Parkinson's
(2.5% CAGR)
The prevalence of Parkinson's Disease is increasing due to:
* Aging population
* Improved diagnostic methods
* Increased awareness
Total Addressable Market
45 billion USD
Market Growth Stage
Pace of Market Growth
Emerging Technologies
AI-Powered Diagnostics
AI-powered diagnostic tools can enable earlier and more accurate Parkinson's diagnosis, improving patient outcomes and facilitating timely intervention.
Telehealth & Remote Monitoring
Telehealth and remote patient monitoring platforms can expand access to specialized care and support for individuals with Parkinson's, particularly in underserved areas, and allow continuous tracking of symptoms and medication adherence.
Wearable Technology & Assistive Devices
Wearable sensors and assistive technology can provide real-time feedback and assistance with movement, balance, and other motor symptoms, improving independence and quality of life for people with Parkinson's.
Impactful Policy Frameworks
National Institutes of Health (NIH) Funding Initiatives
The NIH provides significant funding for research into neurological disorders, including Parkinson's disease, and supports various research initiatives and grant programs aimed at advancing the understanding, treatment, and prevention of these conditions (ongoing). These initiatives vary each year, but consistently have a positive impact on medical research in Parkinson's Disease.
Increased funding for research into neurodegenerative diseases, including Parkinson's, may lead to faster breakthroughs in treatment and care, benefiting APDA's research initiatives.
Expansion of Telehealth Services (Ongoing)
Changes in regulations and reimbursement policies that expand access to telehealth services, particularly for chronic conditions like Parkinson's disease, enable remote monitoring, virtual consultations, and online support groups. CMS has expanded access to telehealth services and coverage during and beyond the COVID-19 pandemic, making it easier for patients to receive care remotely.
Increased access to telehealth services and coverage for Parkinson's patients can broaden APDA's reach and enable more individuals to benefit from their programs and resources.
HIPAA (Health Insurance Portability and Accountability Act) Compliance (Ongoing)
HIPAA establishes standards for protecting sensitive patient health information, requiring healthcare organizations and their business associates to implement safeguards to ensure the privacy and security of medical data. Compliance with HIPAA is crucial for maintaining patient trust and avoiding penalties.
Regulations concerning patient data privacy and security affect how APDA collects, stores, and shares information, requiring them to implement robust data protection measures and comply with privacy regulations.
Transform Your Ideas into Action in Minutes with WaxWing
Sign up now and unleash the power of AI for your business growth
